Various groups have demonstrated a “proliferative burst” of systemic CD8 PD‐1+ T‐cell subpopulations after PD‐L1/PD‐1 blockade in several cancer types which correlate with clinical responses (Huang et al, 201v7; Kamphorst et al, 2017; Kim et al, 2019). This evidence concerns the gene CD274 and cancer.